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Abstract
Plasma lipoprotein(a) ILp(a)I, a low density lipoprotein parti-
cle with an attached apolipoprotein(a) Iapo(a)J, varies widely
in concentration between individuals. These concentration dif-
ferences are heritable and inversely related to the number of
kringle 4 repeats in the apo(a) gene. To define the genetic
determinants of plasma Lp(a) levels, plasma Lp(a) concentra-
tions and apo(a) genotypes were examined in 48 nuclear Cau-
casian families. Apo(a) genotypes were determined using a
newly developed pulsed-field gel electrophoresis method which
distinguished 19 different genotypes at the apo(a) locus. The
apo(a) gene itself was found to account for virtually all the
genetic variability in plasma Lp(a) levels. This conclusion was
reached by analyzing plasma Lp(a) levels in siblings who
shared zero, one, or two apo(a) genes that were identical by
descent (ibd). Siblings with both apo(a) alleles ibd (n = 72)
have strikingly similar plasma Lp(a) levels (r = 0.95),
whereas those who shared no apo(a) alleles (n = 52), had
dissimilar concentrations (r = -0.23). The apo(a) gene was
estimated to be responsible for 91% of the variance of plasma
Lp(a) concentration. The number of kringle 4 repeats in the
apo(a) gene accounted for 69% of the variation, and yet to be
defined cis-acting sequences at the apo(a) locus accounted for
the remaining 22% of the inter-individual variation in plasma
Lp(a) levels. During the course of these studies we observed
the de novo generation of a new apo(a) allele, an event that
occurred once in 376 meioses. (J. Clin. Invest. 1992. 90:52-
60.) Key words: apolipoprotein (a) . lipoprotein (a) * low density
lipoprotein
Introduction
Lipoprotein(a) [Lp(a)]' is a cholesterol ester-rich plasma li-
poprotein comprising two attached components: a low density
lipoprotein (LDL) particle and a single large glycoprotein, apo-
lipoprotein(a) [apo(a)] (1-3). High plasma levels of Lp(a)
are associated with the development of coronary atherosclero-
sis (4-6) and other vascular diseases (7). The mechanism by
which Lp(a) expedites the atherosclerotic process is not
known. Apo(a) strongly resembles plasminogen, and it may
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competitively interfere with plasminogen action in fibrinolysis
(8, 9).
Plasma concentrations of Lp(a) vary over a wide range
among individuals, but are remarkably stable in any given indi-
vidual (10). Many physiological, pharmacological, and envi-
ronmental factors that affect the levels ofother plasma lipopro-
teins have no effect on the plasma concentration of Lp(a)
(10). This lack of environmental and physiological influences
suggests that plasma Lp(a) levels are largely genetically deter-
mined. Consistent with this formulation, early genetic studies
suggested that the presence ofLp(a) in plasma was inherited as
an autosomal dominant trait (1 1-13). When more sensitive
immunoassays of plasma Lp(a) concentrations were used, it
was found that plasma Lp(a) concentrations varied continu-
ously among individuals ( 14), and the pattern of inheritance
indicated that a major gene, as well as polygenic factors, con-
tributed to plasma Lp(a) concentrations (15-17 ).
Fless et al. ( 18) and Utermann et al. (19) found that the
apo(a) glycoprotein varied in size among individuals. In an
important series of studies, Utermann and his colleagues dem-
onstrated that the size ofthe apo(a) protein is inversely related
to the level of plasma Lp(a), thus implicating the apo(a) gene
as a major determinant of plasma Lp(a) concentrations (20-
23). However, the immunoblotting technique used to type the
apo(a) isoforms was not sensitive enough to detect low levels
of apo(a) protein, and not all of the apo(a) isoforms were
detected. As a result, the frequency distribution of the apo(a)
isoforms failed to fit the expectations ofHardy-Weinberg equi-
librium (22). In addition, when immunoblotting was em-
ployed to examine the segregation of the apo(a) isoforms in
families, the results were frequently uninformative, and occa-
sionally inconsistent (24). Further progress required the devel-
opment of a technique that was more discriminating than im-
munoblotting in classifying apo(a) alleles.
A potential method to study this polymorphism was sug-
gested by the findings ofMcLean et al. who discovered that the
apo (a) cDNA contains multiple tandem copies of a sequence
that encodes a cysteine-rich protein motif called a kringle. The
repeated kringle in apo(a) is designated kringle 4 because it
closely resembles the fourth kringle in plasminogen. McLean et
al. proposed that the apo(a) isoforms are of different size be-
cause of variations in the numbers of kringle 4-encoding re-
peats in the apo(a) gene (25). This hypothesis was supported
by studies ofthe apo(a) mRNA and gene structure (26-28). In
attempt to devise a way to measure the size of the apo(a) gene
in different individuals, we previously identified a large restric-
tion fragment from the apo(a) gene which contains most, ifnot
all, of the kringle 4-encoding sequences (29). The size of this
fragment was too large to be examined by standard electropho-
resis techniques. Accordingly, we used pulsed-field gel electro-
phoresis to size this large restriction fragment and 19 fragments
of different length were identified. A total of 103 unrelated
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Caucasians were evaluated and 94% were heterozygous for
fragments oftwo different sizes. The length polymorphism was
used as a genetic marker to analyze the segregation of the
apo(a) gene in 12 Caucasian families. It was found that within
a given family, sibling pairs with identical apo(a) genotypes
tended to have very similar plasma Lp(a) levels (29). How-
ever, individuals with the same apo(a) genotypes who were
members of different families often had significantly different
plasma concentrations of Lp(a). Taken together, these obser-
vations suggest that the apo(a) gene is the major determinant
ofplasma Lp(a) levels and that cis-acting DNA sequences at or
near the apo (a) locus, other than the number of kringle 4 re-
peats, contribute importantly to plasma Lp(a) concentrations.
In the current study, we analyzed the segregation of the
apo(a) gene and Lp(a) levels in 48 Caucasian pedigrees to
determine the contribution of the apo(a) gene (or closely
linked loci) to the plasma concentrations ofLp(a). The genetic
architecture (30) of plasma Lp( a) concentrations was defined
at three levels: the polygenic heritability, the total genetic con-
tribution ofthe apo(a) gene, and the effects of length variation
in the apo (a) gene. In addition, we describe the de novo genera-
tion of a new apo(a) allele of different size within a family.
Methods
Subjects. Plasma Lp(a) concentrations were measured in a sample of
288 fasting individuals from 48 Caucasian American families living in
the greater Dallas, Texas area. Families in which both parents and at
least three children were available for sampling were selected for study.
None of the families had evidence of a monogenic hyperlipidemia. In
one family, F153, several members (who are denoted in Table II) had
very low LDL-cholesterol levels, suggesting the possible existence of
familial hypobetalipoproteinemia. For the random effects analysis of
variance (see below), the families were augmented with a sample of
107 unrelated individuals. Preliminary findings on a subset of these
unrelated individuals have been reported previously (29).
Phlebotomy was carried out after an overnight fast. A total of 30 ml
of blood was collected from each individual in vacutainer tubes con-
taining sodium-EDTA. The plasma was separated within one hour of
collection by centrifugation at 2,000 g for 15 min at 4VC. Multiple 50 ,d
aliquots ofplasma were stored at -70'C and Lp(a) levels were assayed
within 4 wks.
Pulsed-field gel analysis of the apo(a) gene. A total of 15 ml of
blood was maintained at room temperature prior to transfer to two
LeucoPREP tubes (Becton, Dickinson & Co., Lincoln Park, NJ).
Lymphocytes were isolated and embedded in agarose plugs as previ-
ously described (29). The agarose-cellular plugs were incubated twice
with 40 U ofKpnI in 170 ul ofthe buffer suggested by the manufacturer
(New England Biolabs, Beverly, MA). The digested cellular-agarose
plugs were subjected to pulsed-field gel electrophoresis in a vertical
submarine gel apparatus with a transverse alternating field (Geneline I,
Beckman Instruments, Inc., Fullerton, CA) using low-endosmosis coef-
ficient agarose, TAFE buffer, and X phage concatamer standards
(Beckman Instruments, Inc.) as described by Lackner et al. (29). After
18 hours of electrophoresis, the gel was stained with ethidium bromide
and photographed. The DNA was transferred and fixed to nylon mem-
brane (Biotrans, ICN Biomedicals, Costa Mesa, CA). MP-1, a 1.5-kb
PstI genomic fragment from the kringle 4-encoding region of the
apo(a) gene (29) which had been subcloned into MI 3mp 18, was used
to generate a 32P-radiolabeled single-stranded probe (31). The filter
was incubated overnight at 42°C in hybridization solution containing 5
X 106 cpm/ml ofthe single-stranded apo(a)-specific probe. Hybridiza-
tions were carried out in a rotating incubator (model 310, Robbins
Scientific Corp., Sunnyvale, CA). Filters were washed as described by
Lackner et al. (29) and exposed to film.
Immunoblotting ofplasma apo(a). An aliquot of frozen plasma
(between 1 and 30 Itl) containing 1 Aig of Lp(a) was brought up to a
total volume of 30 Al using phosphate-buffered saline. The sample was
mixed with 20 til of buffer A which contained 15% filtered SDS (wt/
vol), 8 M urea, 5 mM dithiothreitol, and 62.5 mM Tris at pH 7.5 and
with 50 ul buffer B (10% glycerol [vol/vol], 2.3% SDS [wt/vol],
0.025% bromophenol blue [wt/vol], 5% fl-mercaptoethanol [vol/
vol], and 50.0 mM Tris at pH 6.8). The samples were boiled for 10
min before loading onto a 3-7% gradient polyacrylamide gel with SDS.
A total of 1 gg of purified LDL (molecular weight of apo B is - 513
kD) was used as a size standard. The electrophoresis, transfer to nitro-
cellulose, and hybridization conditions were exactly as preciously de-
scribed except that IgG-IA2, the apo(a)-specific antibody, was radiola-
beled directly with 1251 to a specific activity of 5 x 106 cpm/ml (29).
The filters were washed, dried and exposed to XAR-5 film (Eastman
Kodak Co., Rochester, NY) at -70°C with an intensifying (Lightening
Plus, Dupont Co., Wilmington, DE).
Plasma lipid and lipoprotein assays. Measurement of plasma
Lp(a) concentrations were performed at GeneScreen, Dallas, TX, us-
ing a sensitive enzyme-linked immunosorbent sandwich assay
(ELISA), as described (32). In this assay, Lp(a) was captured by a
polyclonal rabbit anti-human Lp(a) antibody and then detected by a
monoclonal anti-human Lp(a) antibody, IgG-IA2. Plasma Lp(a)
standards were obtained from Immuno, Vienna, Austria. Total choles-
terol and triglyceride levels were measured enzymatically using com-
mercially available kits (Boehringer Mannheim, Indianapolis, IN;
Sigma Chemical Co., St. Louis, MO). Plasma lipoproteins were quan-
tified in the laboratory of Dr. Scott Grundy (University ofTexas South-
western Medical Center) according to the procedures of the Lipid Re-
search Clinic (33).
Statistical methods. The distribution of plasma Lp(a) concentra-
tion was positively skewed in these data, and thus all analyses were
carried out both on the raw and square-root transformed data. For each
analysis, the primary inferences were identical whether the raw or
transformed data was used.
The contribution ofunmeasured polygenic variation to the inter-in-
dividual variability of plasma Lp(a) concentrations (ap(a)2) was as-
sessed from the extent of familial aggregation of Lp(a) levels in the
sample of pedigrees. The ratio of the polygenic variance component
(apg2) to aLp(a)2 was estimated by maximum likelihood principles as
implemented in the computer program PAP V3.0 (34).
Sibling-pair linkage methods were used to estimate the overall con-
tribution of genetic variation in and around the apo(a) gene (Oapo(a)2)
to plasma Lp(a) levels (35, 36). These methods are most frequently
employed to detect linkage between a marker and a quantitative trait
locus, but can also be used to define the overall contribution of a candi-
date gene to a quantitative phenotype. For each sibling pair, three new
variables were considered: yj, the squared difference of plasma Lp(a)
concentrations in sibshipj,f;j, an indicator variable describing whether
or not thejth sib pair shares only 1 allele identical by descent (ibd), and
7rj, the proportion of alleles ibd in sibshipj. irj can take on the values 0,
1/2, or 1. E(yj) is the expected value of an individual's Lp(a) concentra-
tion. Assuming there is no recombination as would be the case for a
candidate gene, Haseman and Elston (30) show that:
E(yj)= a + ~rj+ 7fj (1)
where
a = 2aapo(a) + Or e
=
-2aapo(a)2
= od.
(2)
(3)
(4)
In Eqs. 2-4, a,2 is a residual variance component describing the effects
of factors other than the apo(a) gene on Lp(a) levels, and ad2 describes
the dominance effects at the apo(a) locus on Lp(a) levels. An estimate
ofthe overall contribution of the apo(a) gene to plasma Lp(a) concen-
trations can be made by examining the regression of the squared differ-
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Table L Correlations ofPlasma Lp(a) Concentrations between Family Members
n Lp(a) VLp(a)
Spouses 48 0.17 [-0.12, 0.43]* 0.17 [-0.12, 0.43]
Parent-offspring 400 0.44§ [0.36, 0.52] 0.48§ [0.40, 0.55]
Midparent-offspring 200 0.59f [0.49, 0.67] 0.61§ [0.51, 0.69]
Siblings (all) 284 0.28§ [0.16, 0.39] 0.32§ [0.21, 0.43]
Siblings sharing no alleles ibd 52 -0.23 [-0.47, 0.05] -0.25 [-0.48,0.02]
Siblings sharing one allele ibd 159 0.15 [-0.16, 0.30] 0.19t [0.04, 0.34]
Siblings sharing two alleles ibd 73 0.95§ [0.92, 0.97] 0.96§ [0.94, 0.97]
* 95% confidence interval. t P < 0.05. § P < 0.001.
ence between the Lp(a) levels of siblings who share none, one, or all
apo(a) alleles ibd. The regression analyses were performed both un-
weighted and weighted, as suggested by Amos et al. (36), with nearly
identical results. Therefore, only the results ofthe unweighted analyses
are presented. Even though the sibships were typically larger then size
two, the above method has been shown to be valid when overlapping
sibling pairs are analyzed as though they were independent (36).
The contribution of length variation in the apo(a) gene, as mea-
sured by pulsed-field gel electrophoresis, to Lp(a) concentrations,
a ,egff2, was estimated using a random effects analysis ofvariance (37).
A random effects or type II model was selected because of the large
number of potential genotypes at the apo(a) locus (38).
Results
Plasma Lp(a) concentrations were measured in 288 individ-
uals from 48 pedigrees. There was no significant effect of age,
sex, or the concentration of other plasma lipoproteins on the
plasma level of Lp(a), so these factors were not considered
further in the family members (data not shown). There were
significant correlations between the plasma Lp(a) levels ofpar-
ents and offspring (r = 0.44), and siblings (r = 0.28), but not
between spouses (r = 0.17) (Table 1). By using standard bio-
metrical genetic analyses, it was estimated that 85% (±8%) of
the inter-individual variance of Lp(a) concentrations was at-
tributable to polygenic effects (apg2/ aLp(a)2) (or 88% (±6.5)
when the square-root of the plasma Lp(a) levels was used).
Pulsed-field gel electrophoresis and genomic blotting of
KpnI digested-genomic DNA was performed to assess the size
of the kringle 4-encoding region of the apo(a) alleles in each
family member. 16 of the 19 previously described apo(a) al-
leles were observed in the sample, and their frequencies did not
differ significantly from those previously described from the
same population (29). In general, there was an inverse rela-
tionship between the size of the apo(a) allele and the plasma
level of Lp(a). One way to illustrate this phenomenon is to
examine the relationship between the plasma Lp(a) concentra-
tions and the apo(a) allele size in the individuals who had one
of the two most common alleles, apo(a) 14 or apo(a) 15 plus a
different allele (Fig. 1). Individuals with one copy ofapo(a) 14
or apo(a) 15 plus one copy ofapo(a)2-apo(a)4 tended to have
high plasma Lp(a) levels (> 30 mg/dl). If the second allele
was apo(a)S-apo(a) 7, the Lp(a) levels were lower (15-30 mg/
dl). If the second allele was larger than apo(a) 8, the plasma
concentrations of Lp(a) were low [< 10 mg/dl, excluding
apo(a) 10].
In the population as a whole, different apo(a) genotypes, as
determined by pulsed-field gel electrophoresis, were associated
with significantly different plasma levels of Lp(a) (P < 0.001
for both the raw and transformed data). A random effects anal-
ysis of variance (37) was used to determine the contribution of
the length variation in the apo(a) gene to the distribution of
plasma Lp(a) in 203 unrelated Caucasians. For the raw data,
69% of the variation in Lp(a) concentrations was attributable
to inter-individual differences in the number of kringle-4 re-
peats. The square-root transformation had little effect on this
value (66% vs. 69%).
Although length variation in the apo(a) gene had a pro-
found influence on Lp(a) concentrations, there were several
exceptions to the general trend. Fig. 2 shows two pedigrees in
which an apo(a) allele ofthe same size, apo(a)6, segregates. In
the two pedigrees this allele gives rise to very different plasma
concentrations of Lp(a). In A, the apo(a)6 allele ofthe father
(a), is inherited by three of his offspring (c, d, and f). The
father, as well as the three offspring, have modest plasma Lp(a)
concentrations (6 mg/dl, and 7, 5, and 3 mg/dl, respectively).
In the family shown in B, individual h, who is also heterozy-
gous for an allele the size of apo(a)6, and has a high plasma
Lp(a) concentration (51 mg/dl). Of her four children, only
the second child (j) inherited apo(a)6 and she is the only off-
spring with a comparable plasma level of Lp(a) (51 mg/dl).
Therefore, in these two families, the same sized apo(a) allele
(apo(a)6) segregated with very different plasma levels of
Lp(a). This was true even though the other alleles at the
apo(a) locus in the families were similar (apo(a) 13-
apo(a) 17). These findings suggest that factors at the apo(a)
50
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Figure 1. Lp(a) levels in individuals heterozygous for apo(a) 14 or
apo(a) 15 allele. In the sample of 288 family members and 107 unre-
lated individuals, there were 194 individuals with either apo(a) 14
or apo(a) 15. The average Lp(a) levels (y-axis) for individuals with
each genotype are plotted against the other apo(a) allele (x-axis).
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Figure 2. Genomic blot of the apo(a) gene
from two unrelated families with apo(a)6.
High molecular weight leukocyte DNA
from members of two unrelated families
was digested with KpnI, size-fractionated
on a pulsed-field gel, transferred to a nylon
membrane, and hybridized with a single-
stranded apo(a)-specific probe (MP-1) as
described in the Methods. The filter was
exposed to Kodak XAR-5 film for 18 h
with an intensifying screen. The plasma
concentrations of Lp(a) were measured us-
ing an ELISA assay as described in the
Methods. The apo(a)6 allele segregates
with a low (A) and high (B) plasma con-
centration of Lp(a) in two different pedi-
grees.
locus, in addition to the number of kringle 4 repeats, strongly responsible for the observed differences in plasma Lp(a) con-
influence the plasma Lp(a) concentration. centrations in individuals with apo(a) alleles of the same size,
Another instance in which apo(a) alleles of the same size the plasma Lp(a) concentrations were compared in sibling
are associated with different amounts of circulating apo(a) pairs who shared all, one, or no apo(a) alleles ibd. In 40 of the
protein, is shown in Fig. 3. In this family, the mother (b) is 48 families, all four parental apo(a) alleles could be differen-
homozygous for apo(a) 12, so all of the children (c-f) are het- tiated using pulsed-field gel electrophoresis. In six families (in-
erozygous for that allele. Based on the genomic blot, it cannot cluding the one shown in Fig. 3), the length polymorphism was
be determined which of the two apo(a) 12 alleles each child uninformative because one of the parents was apparently ho-
inherited from their mother. However, analysis of the apo(a) mozygous for the same sized apo (a) allele, and in two families
protein isoforms reveals that three of the offspring (c, d, andf) one parent was not available for sampling; these eight families
have no detectable apo(a) protein corresponding to apo(a) 12. were not included in the sibling-pair analysis. The families
Only offspring e has a band the same size as the isoform of the were selected at random, so in some families all the plasma
mother. This suggests that the mother is heterozygous and has concentrations of Lp(a) were low (i.e., <5 mg/dl) reflecting
one apo(a) 12 that produces no detectable circulating apo(a) the highly skewed distribution of plasma Lp(a) levels in the
protein which she gave to c, d, and fand another that is asso- Caucasian population.
ciated with the production of a moderate amount of apo(a) In the 40 families in which the segregation of each parental
protein which she donated to offspring e. allele could be distinguished, 72 sibling pairs shared both, 52
To confirm that cis-acting sequences at the apo(a) locus are shared none, and 159 pairs shared one parental allele ibd. The
apo(a) genotypes and plasma Lp(a) levels of these sibling pairs
are given in TableII and can be compared to those of the other
siblings and parents. The sibling pairs who had plasma levels of
a) Lp(a) that were similar to each other and significantly different
from the other siblings are denoted by an asterisk. In 24 fami-
lies, at least one sibling pair had inherited identical apo(a)
alleles and one sibling pair had no apo(a) alleles ibd (Table
Apo(a) 14 1214 12 14 12 III). In 21 of the 24 sibling pairs (denoted by asterisks), theGenotype 8 12 12 8 12 8 mean difference between plasma Lp(a) levels in the sibling
pair who shared no apo(a) alleles ibd was twice that of the
-16 sibling pair who shared both apo(a) alleles ibd.
Pulsed-field db *5 . - Fig. 4 shows the scatter plot of Lp(a) levels of siblings pairsElectrophoresis 4 - that share (A) both or (B) no apo(a) alleles ibd. Lp(a) levels
4 for the older (sibling 1) and younger (sibling 2) sibling are
plotted on the horizontal and vertical axis, respectively. The
correlation coefficient for Lp(a) levels between siblings who
* share both apo(a) alleles ibd was very high (r = 0.95), whereas
Immunoblot there was a negative correlation (r = -0.23) between the Lp(a)
U t concentration of siblings who share no apo(a) alleles ibd. Simi-w *513 kD lar results were obtained for the square-root transformed data
Lp(a) (mg/dl) 16 8 6 1<11 9 |<1 (Table I). Owing to the highly skewed distribution of Lp(a) in
the population, many of the sibling pairs had very low Lp(a)
Figure 3. Genomic blot of apo(a) gene and immunoblot of apo(a) levels. Therefore, the same comparison was made in the sibling
protein in a pedigree. The plasma Lp(a) concentrations were mea- pairs with apo(a) alleles ibd (n = 48) who had plasma Lp(a)
sured and the genomic blot and immunoblot was performed as de- levels over 5 mg/dl and the correlation coefficient remained
scribed in Fig. 2 and in the Methods. very high (r = 0.94).
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Table II. Apo(a) Genotypes and Lp(a) Levels in Sibling Pairs with Apo(a) Alleles ibd and Their Family Members
Sib with identical apo(a) genotypes Other Sibs Parents (father, mother)
Family Apo(a) Apo(a) Plasma Apo(a)
no. genotype Plasma Lp(a) genotypes Lp(a) genotype Lp(a)
mg/dl
26 41 13/16, 15/16, 2/15
*40 *42 *55 12/17, 12/17
*44 *47 *58 5/14
*41 *42 10/14,6/14
58 34 12/15, 4/15, 4/15
*49 *52 13/13
*36 *48 8/14
*47 *49 10/15
*55 *56 *66 14/15, 14/15
32 43 12/15, 4/10, 4/10
*49 *56 9/16
64 98 11/16, 11/16, 12/16, 5/11
7 7 6/16, 6/16, 15/16
5 7 14/17, 6/17
5 6 15/16, 6/6, 6/6
*28 *44 9/17, 9/11, 9/11
5 7 12/13, 13/15
4 6 8 7/15
5 6 9/17, 7/11, 7/11
*7 *9 4/16, 5/9, 4/5
6 8 11 16/17, 9/18
< 1 3 13/14, 13/14, 13/14
< I < 1 15/17, 8/11
1 2 14/15, 14/15, 14/15, 7/11
1 1 1 15/16
*< 1 *3 12/16, 5/11, 5/12, 5/12
*15 *15 *21 12/17, 13/13
1 5 13/15
*< I *< 1 8/13
*3 *6 10/15, 10/14
1 1 14/15, 7/12
*< 1 *< 1 2/17, 2/17, 2/17
<1 < 1 15/18
1 1 < 1 10/13, 10/13
4 4 16/17, 15/17, 8/16
*3 *3 4/15, 4/15, 4/15
< I < 1 < 1 11/15, 11/15, 7/11
<1 <1 4 15/18
1 1 3 14/15, 15/17
8 8 15/18, 15/18
5 9 16/17, 16/17, 6/15
1 5 2 10/17
*It *44 *5t 7/16
3 5 15/16, 15/16, 6/15
< 1 9 14/18, 14/18
mg/dl
1, 6, 32 2/16, 13/15
< 1, < 1 6/17, 2/12
21 5/15,4/14
< 1, 16 4/14, 6/10
14, 32, 43 10/15, 4/12
10 4/13, 13/14
10 4/8, 14/15
7 14/15,4/10
3,3 14/15,4/14
14, 34, 58 10/15, 4/12
4 5/16,9/10
< 1,3,8,51 5/16, 11/12
5,6,6 6/15,6/16
2, 3 6/14, 13/17
6,7,7 6/15,6/16
< 1,5,6 7/9, 11/17
17, 19 8/13, 12/15
5 15/16,7/8
< 1,28,44 7/9, 11/17
22,50,75 5/16,4/9
12, 12 9/16, 17/18
< 1, 1, 1 10/14, 13/15
< 1,7 8/15, 11/17
< 1,< 1,< 1, 17 7/15, 11/14
3 11/16,8/15
8, 51, 64, 98 5/16, 11/12
1, 5 13/17, 12/13
1 14/15, 12/13
16 12/13,8/14
21, 34 10/12, 14/15
< 1, 28 12/14, 7/15
40, 42, 55 6/17, 2/12
< 1 12/15, 9/18
< 1, 3 10/14, 13/15
< 1, 3, 3 13/17, 15/16
56, 56, 66 14/15, 4/14
1,2,17 7/15, 11/14
< 1 14/18, 5/15
2, 3 14/17, 14/15
< 1, 9 14/15, 10/18
3,5,51 15/17,6/16
< 1 16/17, 10/15
27 7/16, 12/16
5,9,51 15/17,6/16
8, 8 14/15, 10/18
* Sibling pairs with identical apo(a) genotypes who have Lp(a) levels which are significantly different from all the other siblings. t These indi-
viduals have a plasma LDL-cholesterol concentration less than the 5th percentile when compared to age and sex-matched controls.
The overall contribution of the apo(a) gene to plasma significantly different from zero (y = 1.27 for untransformed
Lp(a) concentrations was estimated by examining the regres- Lp(a) levels) so was not considered in further analyses. The
sion of the squared difference of Lp(a) levels between siblings simple linear regression of the squared difference of Lp(a) lev-
(yj) based on the proportion of apo(a) alleles shared ibd (w1j). els between siblings on the proportion of apo(a) alleles shared
The dominance deviations at the apo(a) locus ('y) was not ibd is graphically presented in Fig. 5. The average squared dif-
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1. F141
2. F168
3. F162
4. F24
5. F154
6. F161
7. F158
8. F156
9. F135
10. F154
11. F142
12. F145
13. F129
14. F149
15. F129
16. F146
17. F166
18. F150
19. F146
20. F124
21. F134
22. F137
23. F21
24. F143
25. F164
26. F145
27. F167
28. F138
29. F152
30. F160
31. F125
32. F168
33. F126
34. F137
35. F136
36. F135
37. F143
38. F131
39. F132
40. F165
41. F157
42. F159
43. F153
44. F157
45. F165
2/13
2/17
4/5
4/10
4/10
4/13
4/14
4/15
4/15
4/15
5/9
5/12
6/6
6/13
6/16
7/11
8/12
8/15
9/11
9/16
9/17
10/13
11/15
11/15
11/15
11/16
12/13
12/14
12/14
12/14
12/15
12/17
12/18
13/14
13/15
14/15
14/15
14/15
14/17
14/18
15/16
15/17
16/16
16/17
15/18
mg/dl
36, 6
40, 54
38, 19
31, 62
32, 52
50, 9
48, 7
4,42
4,45
32, 52
72, 21
47, 5
4, 15
6, 15
4, 15
22, 9
9, 10
5, 5
22, 9
54, 27
15, 3
< 1,2
5,< 1
28, < 1
2,4
47, 5
12, 1
4, 2
< 1, 30
27, 10
< 1, 32
40, 54
3,< 1
< 1,2
1,9
4,45
28, < 1
< 1, <1
8,< 1
16, < 1
4,51
< 1,6
52, 1
4,51
16, 1
Table III. Lp(a) Levels in Sibling Pairs in the Same Family
Who Share Both or No Apo(a) Alleles Identical by Descent
Siblings sharing both apo(a)
alleles Siblings sharing no apo(a) alleles
Lp(a) Genotype Lp(a)
Family Genotype Sibl Sib2 SibI Sib2
141* 2/13 41 26 13/16 1 2/15 32
24* 4/10 42 41 4/10 42 6/14 16
154 4/10 58 34 12/15 14 4/10 34
154* 4/15 32 43 12/15 14 4/10 58
124* 4/16 22 36 5/9 50 4/16 22
145* 5/12 98 64 11/16 1 5/12 98
149* 6/13 7 5 6/13 7 14/17 2
146* 7/11 44 28 7/11 44 9/17 1
166* 8/12 5 7 8/12 5 13/15 19
146* 9/11 5 6 9/17 1 7/11 28
124* 9/16 9 7 9/16 9 4/5 75
134 9/17 11 8 9/18 12 16/17 12
21* 11/15 1 1 15/17 1 8/11 7
143* 11/15 2 1 7/11 17 14/15 1
145* 11/16 1 3 12/16 8 5/11 51
138 12/14 1 5 13/15 1 12/14 1
160* 12/14 3 6 10/15 21 12/14 3
152* 12/14 1 1 12/14 1 8/13 16
125* 12/15 1 1 7/12 28 14/15 1
136* 13/15 4 4 13/15 4 8/16 3
143* 14/15 1 1 7/11 17 14/15 1
143* 14/15 1 1 7/11 17 14/15 1
157* 15/16 5 9 6/15 51 16/17 5
157* 16/17 5 3 6/15 51 16/17 3
* The difference in Lp(a) levels in the siblings sharing no apo(a) alleles
is at least twice that of the siblings sharing both alleles.
ferences are 1248, 654, and 58 (mg/dl)2 for those sibling pairs
that share no, one, and both of their apo(a) alleles ibd, respec-
tively. There was a heteroscedastic distribution of squared
Lp(a) differences among the three groups, so weighted regres-
sion analysis was performed, as suggested by Amos et al. (36);
the results were similar for the weighted and unweighted analy-
ses (data not shown). The linear regression line that best fits
these data was equal to yj = 1249.2 - 1190.6iy. These parame-
ter estimates combined with algebraic manipulation of Eqs. 2
and 3 yield estimates of a po(a)2 and the residual variance com-
ponent, Oe2. For the raw untransformed data, apo(a)2 and ae2
were equal to 595.3 and 58.6, respectively. As a ratio, these
results indicate that 91% of the variation of plasma Lp(a) con-
centrations among individuals was attributable to genetic varia-
tion in the apo(a) gene (a apo(a)2/Iapo(a)2 + ae2). For the square-
root transformed data these values were 7.00%, 0.86%, and
89%, respectively.
Finally, given the extensive degree of size heterogeneity at
the apo(a) locus, it would have been expected that new apo(a)
alleles would be encountered if a sufficient number of meioses
were analyzed. In this sample, a total of 376 meiosiswere exam-
ined and a single apo(a) allele was found in an offspring that
was not present in either parent (Fig. 6). The fourth child,
individualf, has apo(a) 16 and apo(a) 9. Clearly, he inherited
apo(a) 16 from his mother, but his father does not have
apo(a) 9. Paternity testing was performed using 7 unlinked
varying number oftandem repeat (VNTRs), and in each case,
the genotype of individual f was consistent with individual f
being the child of individual a (39). The calculated probability
of individual a not being the true father was < 1 x 10-6 (data
not shown). Therefore, a mutation must have occurred in a
paternal gamete which resulted in the generation of an apo (a)
allele of different size.
Discussion
In this article we have evaluated the segregation of the apo(a)
gene and plasma Lp(a) levels in 48 Caucasian families and
found that virtually all the inter-individual variation in plasma
Lp(a) levels was attributable to the genomic region encoding
the apo(a) glycoprotein. It had been clear from previous family
studies that plasma Lp(a) levels are largely genetically deter-
mined; prior estimates of the heritability of plasma Lp(a) lev-
els have ranged from 0.75 to 0.98 (15, 17, 40, 41) which is
comparable to our estimate of 0.85 (±8%). Initially, Lp(a)
could only be detected in the plasma of Lp(a) of a third of
individuals, and yet when family studies were performed, the
inheritance pattern suggested a single autosomal dominant
gene (1 1-13, 42-44). When more sensitive radioimmunoas-
A. Apo(a) Alleles ibd B. No Apo(a) Alleles ibd
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Plasma Lp(a) (mg/dl)
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20 40 60 80 Figure 4. Scatter plot of Lp(a) levels for sibling
pairs sharing (A) both (n = 72) or (B) no (n = 52)
apo(a) alleles identical by descent.
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Figure 5. Squared difference between Lp(a) levels of siblings as a
function of the proportion of apo(a) alleles shared
scent. The regression line for the squared difference
of apo(a) alleles shared identical by descent is given.
says were employed to measure plasma Lp(a) concentrations
in families, there was evidence for a major
polygenic factors, contributing to the plasma Lp(a)
17). In one large Caucasian pedigree, a major
alleles was estimated to account for 73% of
Lp(a) levels (16).
The first molecular clue that the apo(a) gene
role in the genetics of plasma Lp(a) concentrations,
observation that the size of the apo(a) glycoprotein
versely related to the plasma level of Lp(a)
and his colleagues estimated that differences in
apo(a) glycoprotein accounted for 41% of
inter-individual plasma Lp(a) levels (22). Further
the apo(a) gene being the major gene influencing
came from linkage analyses between segregation
*4i~~~i-1
Apo(a) 17 16 15 17 15 16 16 17
Genotype 13 15 13 1513 9 13 16
Lp(a) 1 9 4 3 4 3 1 4
(mng/di)_
Figure 6. Genomic blot of kringle 4-encoding
gene in a family in which there is generation (a)
of different length. Southern blotting of the
of the apo(a) gene was performed as described in the Methods and
Fig. 2. Individual f has inherited apo(a) 16
apo(a) 9 from his father. Paternity was confirmed
different VNTR sequences, as described in Methods.
Lp(a) concentrations and DNA sequences in the plasminogen
gene which is closely linked to the apo(a) gene (45, 46).
The present study is distinguished from prior family studies
by the fact that the apo(a) gene, rather than the expressed
protein, was examined in relation to the level of Lp(a)
plasma. In prior studies the immunoblotting techniques
to examine apo(a) isoforms failed to detect protein products
from all apo(a) alleles. Numerous exceptions to inverse
relationship between plasma Lp(a) levels and the the
apo(a) protein were reported. It was suggested that ex-
ceptions were due to the fact that not all apo(a) were
detected using the immunoblotting assay. In this study, apo(a)
alleles associated with little or no production of apo(a) protein
were included in the analysis. As a result, length variation
within the kringle 4-encoding region of the apo(a) ac-
counted for a greater proportion of the inter-individual varia-
tion in plasma Lp(a) concentrations than had been previously
estimated (69% vs. 41% [22]).
The reason for the inverse correlation between the
the apo(a) gene and the level of plasma Lp(a) is known.
Studies in primates have shown that there is not always con-
sistent relationship between the abundance of apo(a) mRNA,
and its size, suggesting that differences in apo(a) gene tran-
scription can not entirely account for this inverse relationship
(26,47). The size of the apo(a) mRNA transcript glycopro-
tein may influence its rate of translation, or intracellular trans-
port, respectively.
Alternatively, the observed inverse relationship may
directly related to the number of kringle 4 repeats
apo(a)
gene, mRNA, or glycoprotein. The apo(a) alleles different
size might be in linkage disequilibrium with the se-
quences at the apo(a) locus that mediate the effect plasma
Lp(a) concentrations. The number of kringle 4 repeats the
apo(a) gene may not have a direct effect on plasma Lp(a)
concentrations. In the marmoset monkey, for example, the
plasma Lp(a) concentrations vary over a 100-fold
and
yet there is only a single apo(a) isoform (48). In current
study, the contribution of the apo(a) gene was partitioned into
two components to demonstrate that sequences apo(a)
locus, other than the number of kringle 4 repeats, contribute
importantly to plasma levels of Lp(a). If, however, number
of kringle 4 repeats in the apo(a) gene are in linkage disequilib-
rium with the actual sequences responsible for mediating the
effect of the apo(a) gene or plasma level of Lp(a), the
contribution of the length polymorphism to the inter-individ-
ual variation in plasma Lp(a) levels has been overestimated.
Another possible cause for individuals with same
apo(a) genotypes having different plasma concentrations of
Lp(a) is that alleles of the same size may differ in composi-
tion of kringle 4 sequences. Not all the kringle sequences are
identical. The first, as well as the last eight kringle repeats, differ
from the common kringle 4 repeat (the so-called "A" repeat)
by between 4 and 35 amino acids (25). Due to frequent
recombinational events involving this locus, is it likely
that apo(a) alleles vary in their kringle 4 composition, well
as number. Subtle differences in the kringle 4 sequences may
impact importantly on the synthesis, and/or degradation
of Lp(a).
The length polymorphism in the apo(a) gene has hetero-
zygosity index comparable to that of number of tandem
repeat
(VNTR) loci employed in forensic and genetic linkage studies
(39,49, 50). The mutation rate at VNTR loci is several magni-
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tudes higher than the usual bi-allelic DNA sequence polymor-
phisms (39, 51). Given the large number of different sized
alleles at the apo(a) locus, a relatively high mutation rate was
expected. Therefore, it was anticipated that mutations in the
gene would be identified ifa sufficient number of families were
analyzed. We have observed one mutation of an apo(a) allele
out of a total of 376 meioses, and this rate is of the same order
of magnitude as the frequency of newly generated alleles for
VNTR sequences (39, 51 ).
Most length polymorphisms in the human genome involve
noncoding sequences. The coding regions of several mamma-
lian genes have short tandem repeats (i.e., less the 50 basepairs)
which are polymorphic in length (52-56). There are also exam-
ples of entire genes being tandemly repeated, as is the case with
rDNA, 5S DNA, and the histone genes. The apo(a) length
polymorphism is distinguished by the fact that the repeated
sequence is large (5.5 kb) and contains both coding and non-
coding sequences. The polyubiquitin gene (UbC), contains a
large length polymorphism within its coding sequence, but all
of the repeated sequences are contained in one exon, and each
of the seven to nine repeats encodes the entire protein (57).
The heterozygosity index of this length polymorphism is low
(22%) compared to the apo(a) gene (94%). The extremely
high degree of heterozygosity at the apo(a) locus may reflect
the fact that it is under less selective pressure. A physiological
function for this enigmatic protein has yet to be identified (2).
Alternatively, there may be something intrinsic to the kringle
4-encoding sequences which make them more susceptible to
recombinational events.
Mutations ofrepeated sequence domains result from either
intrachromosomal or interchromosomal events. Initially, it
was proposed that the mechanism primarily responsible for the
high degree ofsize polymorphism in VNTRs was due to homol-
ogous recombination and unequal exchange during meiosis.
However, molecular analysis of several new mutations re-
vealed no exchange of flanking genetic markers, which suggests
that intrachromosomal, rather than interchromosomal, events
appear to be predominantly responsible (51, 58). Similarly,
recent molecular analysis of tandem duplication within the
Duchenne muscular dystrophy gene demonstrated that the re-
combinational events were due to intrachromosomal unequal
exchange between sister chromatids rather than involving ho-
mologous chromosomes (59, 60). Efforts are now being di-
rected to identify polymorphisms flanking the apo(a) gene to
analyze the nature of the mutational event(s) responsible for
the observed size heterogeneity at the apo(a) locus.
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